OCLGX
Price
$15.57
Change
-$0.04 (-0.26%)
Updated
Dec 3 closing price
Net Assets
2.12B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

OCLGX vs VIGRX

Header iconOCLGX vs VIGRX Comparison
Open Charts OCLGX vs VIGRXBanner chart's image
Optimum Large Cap Growth C
Price$15.57
Change-$0.04 (-0.26%)
VolumeN/A
Net Assets2.12B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
OCLGX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
OCLGX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCLGX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. OCLGX (2.12B). VIGRX pays higher dividends than OCLGX: VIGRX (0.30) vs OCLGX (0.00). OCLGX was incepted earlier than VIGRX: OCLGX (22 years) vs VIGRX (33 years). OCLGX (1.96) is less costly to investors than VIGRX (0.17). OCLGX is a more actively managed with annual turnover of: 54.00 vs. VIGRX (11.00). OCLGX has a lower initial minimum investment than VIGRX: OCLGX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. OCLGX (-0.64). VIGRX return over 5 years is better than : 99.11 vs. OCLGX (-18.91).
OCLGXVIGRXOCLGX / VIGRX
Total Expense Ratio1.950.171,147%
Annual Report Gross Expense Ratio1.960.171,153%
Fund Existence22 years33 years-
Gain YTD15.93419.76481%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets2.12B357B1%
Annual Yield % from dividends0.000.30-
Returns for 1 year-0.6418.49-3%
Returns for 3 years31.50110.8228%
Returns for 5 years-18.9199.11-19%
Returns for 10 years-2.75349.13-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT